News | July 17, 2007

Temperature Modulation Can Save Cardiac Arrest Victims

July 18, 2007 - Cardium Therapeutics and its operating unit, InnerCool Therapies, have released its new CoolBlue surface temperature modulation system and RapidBlue endovascular temperature modulation system used for temperature modulation therapy in cardiac arrest patients.
The CoolBlue system includes a console and a disposable vest with upper thigh pads, which is designed to provide a complementary tool for use in less acute patients or in clinical settings best suited to prolonged temperature management. The vest and thigh pads, which effectively wrap the body without requiring any adhesives contacting the skin, are expected to enable cooling rates of around 1 degree Celsius per hour, similar to those of currently-marketed surface cooling systems and lower-performing endovascular systems using medium-sized, inflatable plastic balloon-based catheters.
InnerCool's approach to endovascular temperature modulation makes use of a thin flexible catheter designed to facilitate quick deployment and minimize vascular occlusion - while at the same time accelerating and optimizing patient cooling and re-warming. InnerCool's next-generation RapidBlue system for high-performance endovascular temperature modulation includes a programmable console with an integrated easy to insert cassette, enhanced touch-screen user interface and a catheter designed to quickly modulate patient temperature in association with surgery or other medical procedures. The RapidBlue system powers InnerCool's Accutrol catheter, which has a flexible, low profile metallic temperature control element and a built-in temperature feedback sensor to provide fast, precise and reliable patient temperature control. Cooling rates with the RapidBlue system range from 4-5 degrees Celsius per hour.

For more information: www.innnercool.com

Overlay Init